Personalized Healthcare sounds like a perfect dream. When every patient immediately gets specifically what she or he needs at that very moment, the quality of healthcare can be maximized while the costs tend to fall. But ist that it? And is it real and true? What does Personalized Healthcare mean and how does it affect the different ankles of the industry? - In two speeches our speakers will share their different point of views regarding the main topic of Personalized Healthcare.
The first Life Sciences Leader Forum was a success. We look forward to welcome you to the next Life Sciences Forum. Please mark your agenda for 2.11.2016.
Event Reports
LSLF #1 – Read the event report by Nadine Nikulski of BaselArea.Swiss
The Life Sciences Leader Forum is an executive community that aims to provide a platform for business and IT leaders to learn and collaborate. This is a place to share different perspectives on the new challenges faced by the industry. The community focuses on how digitization can enable, transform and enhance business initiatives like “Personalised Medicine”, “Patient Experience”, “Mergers & Acquisitions”, “Supply Chain Management” and “Digital Workplaces”.
This forum is your platform to engage with senior executives in life sciences and healthcare. It is designed to discuss opportunities and successful approaches to better lead in a business world with massive disruption. We offer content delivered by industry leaders and a networking opportunity to share insights.
Martin Risau will point out the strategic role of analytics in personalised healthcare based on concrete examples from his work. Hewlett Packard Enterprise delivers solutions that address the most challenging problems companies face in managing information and data assets. The organisation provides services to handle both structured and unstructured data, leveraging “big data” to drive business outcomes for clients.
The Future of Personalised Healthcare: The Importance of Diagnostics and Molecular Information - An Industry Perspective
Miro Venturi leads the global personalised healthcare initiative at Roche. He has contributed the biomarker and personalised medicine strategies and directed global drug development programmes. Miro is an enthusiastic professional, with many years of experience in different roles in pharmaceutical companies such as Pfizer and Novartis. Miro Venturi holds a PhD from the Max Planck Institute of Biophysics in Frankfurt. He is specialised in molecular medicine, virology and immunology. In his speech he will talk about the challenges and opportunities of personalised healthcare for the pharmaceutical industry.